4//SEC Filing
Aralez Pharmaceuticals Inc. 4
Accession 0001104659-16-097854
CIK 0001660719operating
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 9:30 PM ET
Size
4.8 KB
Accession
0001104659-16-097854
Insider Transaction Report
Form 4
Charles Scott J
Chief Financial Officer
Transactions
- Award
Common Shares
2016-02-12+86,863→ 116,000 total
Footnotes (1)
- [F1]Restricted Stock Units granted pursuant to the Aralez Pharmaceuticals Inc. 2016 Long-Term Incentive Plan, which vest 25% annually over four years commencing upon the first anniversary of the Reporting Person's date of hire, subject to continued employment or service to the Company.
Documents
Issuer
Aralez Pharmaceuticals Inc.
CIK 0001660719
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001660719
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 9:30 PM ET
- Size
- 4.8 KB